News

August 3, 2022

Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing Formulation Development & Manufacturing

Article describes Enteris’ strengths and scalability in working with highly potent active pharmaceutical ingredients Boonton, NJ, August 03, 2022  — Enteris BioPharma, Inc., a biotechnology company developing […]
July 14, 2022

Enteris BioPharma Announces Acceptance of Abstract for Oral Presentation at ASRM 2022 Scientific Congress & Expo

Boonton, NJ, July 14, 2022  — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of […]
June 13, 2022

Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference

Data suggest that oral formulations of leuprolide developed utilizing Enteris’ Peptelligence® platform successfully deliver meaningful circulating drug concentrations and achieve hormonal suppressive effects which are comparable to parenteral administration.
June 7, 2022

Enteris BioPharma Publishes White Paper Examining Safe Handling and Manufacture of Highly Potent Active Pharmaceutical Ingredients (HPAPI)

Facilities and processes key to protecting workers and the environment, the paper in Drug Development & Delivery says Boonton, NJ, June 7, 2022  — Enteris BioPharma, Inc., […]
May 26, 2022

Enteris Employees Lend Ronald McDonald House a Helping Hand at Enteris Day 2022

Boonton, NJ, May 26, 2022  — Enteris BioPharma, Inc. gave plush animals a dose of personality as they created a dozen stuffed teddy bears for Ronald McDonald […]
May 4, 2022

Enteris BioPharma to Exhibit at CPhI North America 2022

Boonton, NJ, May 4, 2022  — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of […]
April 12, 2022

Enteris BioPharma Announces Acceptance of Two Abstracts for Presentation at ENDO 2022 Annual Conference

Boonton, NJ, April 12, 2022  — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of […]

KNOWLEDGE CENTER

Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.

LEARN MORE

KNOWLEDGE CENTER

Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.

LEARN MORE